V540B

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V540B, covering 2025-08-03 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of V540B in Healthy Adults (V540B-002). [Phase 1]